Home
About
Overview
Sharing Data
ORCID
Help
History (63)
Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T.
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial.
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).
Dictyocaulus
Prospects for vaccination against herpes simplex virus.
See All 63 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prospects for vaccination against herpes simplex virus.
Prospects for vaccination against herpes simplex virus. Pediatr Ann. 1993 Dec; 22(12):726, 729-32.
View in:
PubMed
subject areas
Herpes Simplex
Humans
Simplexvirus
Vaccination
Vaccines, Attenuated
Vaccines, Inactivated
Vaccines, Synthetic
Viral Vaccines
authors with profiles
Richard Whitley